Salicylic Acid in Acne Products: Concentrations and Label Facts from FDA Data
Salicylic acid is a beta-hydroxy acid (BHA) that appears across a wide range of over-the-counter (OTC) skincare and dermatological products sold in the United States. Official U.S. drug label data — filed by manufacturers and accessible through the openFDA database — reveals how this ingredient is regulated, what concentrations appear on the market, and what disclosures labels are required to carry. The following article summarizes those label facts. It is not medical advice.
Concentrations Found on the Market
According to openFDA label data, salicylic acid appears in OTC products at a range of concentrations depending on the labeled purpose. For acne-related products, labels in the dataset consistently declare a concentration of 2%. This figure appears across cleansers, spot treatments, toners, and general acne treatment formulations. One multi-ingredient product in the dataset also includes salicylic acid at 2% alongside sulphur 5% and benzoyl peroxide 2.5%, all three listed under the purpose “Acne medication.”
For wart-removal products, the concentrations are substantially higher. The dataset contains one wart remover listing salicylic acid at 12% and another at 20%, both carrying the labeled purpose “Wart remover.” These higher-concentration products are not labeled for acne use and carry distinct indications and warnings reflecting their different regulatory classification.
Product Overview Table
| Brand Name | Active Ingredient & Strength | Labeled Purpose |
|---|---|---|
| CeraVe Acne Control Cleanser | Salicylic Acid 2% | Acne treatment |
| Quick Action | Salicylic Acid 2% | Acne medication |
| Clear Acne Spot Treatment | Salicylic Acid 2.0% | Acne treatment |
| Replenix Gly-Sal 10-2 Cleanser | Salicylic Acid USP, 2% | Acne medication |
| Unlabeled multi-ingredient product | Salicylic Acid 2%, Sulphur 5%, Benzoyl Peroxide 2.5% | Acne medication (all three actives) |
| Unlabeled single-ingredient acne product | Salicylic Acid 2% | Acne treatment |
| Unlabeled wart remover | Salicylic Acid 12% | Wart remover |
| Unlabeled multi-ingredient wart remover | Salicylic Acid 20%, Salix Alba Bark 2%, Bifidobacterium Longum 1%, Glycyrrhizinate Dipotassium 0.2% | Wart remover |
What Labels State About Indications
For acne-labeled products, the uses section of OTC labels describes the product’s role in terms of clearing existing blemishes and reducing the formation of new ones. Specific language found across labels in this dataset includes references to clearing acne blemishes, helping prevent new acne blemishes from forming, and reducing the number of pimples, whiteheads, and blackheads. The CeraVe Acne Control Cleanser label, for example, states uses that include clearing acne blemishes and allowing skin to heal, as well as helping prevent new acne blemishes from forming.
For wart-removal products, labels define the conditions the product is intended to address in precise anatomical terms. These include common warts, described on labels as recognizable by a rough, cauliflower-like surface appearance, and plantar warts, identified by their location on the bottom of the foot, tenderness, and interruption of the footprint pattern.
What Labels Are Required to Disclose: Warnings
OTC drug labels in the United States are required to carry standardized warnings. The labels in this dataset reflect several consistent disclosures:
- External use only. Every product in the dataset carries this statement in some form.
- Interaction with other topical acne medications. Several acne product labels note that using more than one topical acne medication simultaneously increases the likelihood of skin irritation and dryness. Labels advise that if irritation occurs, only one topical acne product should be used at a time. The Replenix Gly-Sal label states that using other topical medications while using the product or immediately after may increase dryness or irritation.
- Sensitive skin caution. At least one label in the dataset advises against use by individuals with sensitive skin or known sensitivity to the active ingredient.
- Keep out of reach of children / swallowing hazard. Multiple labels include statements directing users to keep the product out of reach of children and to seek medical help if the product is swallowed.
- Eye and mucous membrane avoidance. The Replenix Gly-Sal label specifically directs users to keep the product away from eyes, lips, and mouth.
- Wart remover-specific warnings. Labels for wart-removal products include additional cautions not present on acne labels. These include warnings against use on moles, birthmarks, warts with hair growing from them, genital warts, or warts located on the face or mucous membranes. The higher-concentration wart remover label also cautions against use by individuals with diabetes or poor blood circulation, and against application to irritated, inflamed, or reddened skin. One wart remover label additionally notes to keep the product away from fire and flame.
A Note on Multi-Ingredient Formulations
The dataset includes at least one product that combines salicylic acid with other active ingredients. In that product, salicylic acid 2%, sulphur 5%, and benzoyl peroxide 2.5% are each individually listed as active ingredients, each carrying the labeled purpose “Acne medication.” This reflects the OTC monograph framework, under which multiple active ingredients may be combined provided each is listed separately with its concentration and purpose.
Frequently Asked Questions
What salicylic acid concentration is used in OTC acne products according to label data?
Based on the openFDA label data reviewed here, all acne-labeled products in the dataset declare a salicylic acid concentration of 2%. No acne-labeled product in this dataset carries a higher or lower concentration.
Are high-concentration salicylic acid products labeled for acne?
No. The products in this dataset carrying concentrations of 12% and 20% salicylic acid are both labeled under the purpose “Wart remover,” not acne treatment. Their indicated uses, warnings, and application instructions differ substantially from the acne-labeled products.
What do labels say about using salicylic acid products alongside other topical acne medications?
Several labels in the dataset specifically flag this scenario. They state that using another topical acne medication at the same time makes skin irritation and dryness more likely to occur, and advise using only one topical acne product at a time if irritation develops.
Do all salicylic acid OTC products carry the same warnings?
Not entirely. While external-use-only language appears across all products in the dataset, warnings specific to wart-removal products — such as cautions about diabetes, poor circulation, and specific wart types to avoid treating — do not appear on acne product labels. Label requirements reflect the product’s classified purpose.
Disclaimer
This article is informational only and does not constitute medical advice. It summarizes publicly available OTC drug label data and makes no recommendations about what products individuals should use. Readers experiencing persistent acne or other skin concerns should consult a licensed dermatologist or qualified healthcare provider.
Data Source
All ingredient concentrations, labeled purposes, indications, and warning details cited in this article are drawn exclusively from the openFDA drug label API (api.fda.gov), a public domain database of official U.S. OTC product label filings. Data was retrieved on 2026-07-18. Label data reflects manufacturer filings and may not represent every product on the market. Product availability and formulations are subject to change.